Suchandrima Bhowmik

Feature Writer

M.Sc. Microbiology

Suchandrima has a Bachelor of Science (B.Sc.) degree in Microbiology and a Master of Science (M.Sc.) degree in Microbiology from the University of Calcutta, India. The study of health and diseases was always very important to her. In addition to Microbiology, she also gained extensive knowledge in Biochemistry, Immunology, Medical Microbiology, Metabolism, and Biotechnology as part of her master's degree.

Suchandrima is also an avid writer and has written for some reputable Indian organizations. However, she decided to pursue scientific writing as it would be the best combination of what she loves, research and writing. Additionally, she authored a book chapter that was published in Elsevier.

Currently she is also working as a medical writer where she has to develop articles for several diseases and also provide detailed descriptions of medicines and other associated products.

She is very enthusiastic about working at AzoNetwork's medical website, News Medical, since it will keep her updated about the latest breakthroughs in medical and health science that are happening around the world.

Apart from science, her hobbies include reading and painting. She has an art page on Instagram with over 1k followers and plans not to lose touch with her hobbies. She loves reading novels, the last novel she read was Men without Women by Haruki Murakami.

See less

Articles from Suchandrima

Study shows school closures can be minimized by regular testing and vaccination against COVID-19

A new study discusses a novel model to determine age-specific differences in susceptibility of infection, contact patterns, and contagiousness to COVID-19.

25 Aug 2021

Study shows difference in antibody levels in response to SARS-CoV-2 infection and type of vaccination

In a recent study, researchers aimed to monitor the levels of the anti-SARS-CoV-2 spike IgG levels in populations that were subjected to routine tests.

24 Aug 2021

Researchers conduct population level observational study of the SARS-CoV-2 Alpha variant

In recent study, researchers analyzed COVID-19 data obtained from Israel to determine whether the Alpha variant led to a higher fatality rate.

24 Aug 2021

Expansion of seasonal betacoronavirus antibodies post-vaccination is associated with reduction in neutralization of the SARS-CoV-2 variants of concern

A new study determined the antibody response to SARS-CoV-2 and seasonal viruses induced by BNT162b2-Comirnaty vaccination in healthcare workers.

23 Aug 2021

How have SARS-CoV-2 variants of concern impacted national case fatality rates?

A new study aims to analyze the degree to which the new VoCs cause fluctuations in daily case fatality rates (CFR) across several countries.

23 Aug 2021

White-tailed deer are highly susceptible to SARS-CoV-2 infection

The SARS-CoV-2 virus has been shown to infect a wide range of animals naturally and experimentally, and prior studies indicate deer are susceptible to infection. White-tailed deer (Odocoileus virginianus) fawns have been found to be susceptible to SARS-CoV-2.

19 Aug 2021

Excess mortality from COVID-19 is the highest since 1918

A recent study provides an assessment of the ongoing pandemic by estimating excess deaths in Sweden, Switzerland, and Spain.

18 Aug 2021

Impact of COVID-19 on the wellbeing of young people

In a recent study, researchers offer recommendations for the wellbeing of children and young people during the pandemic to prevent long-term consequences.

18 Aug 2021

Increased chemosensory dysfunction with D614G mutation of SARS-CoV-2

A study, available on the pre-print server medRxiv, has determined the underlying molecular mechanisms of how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), especially the G614 strain, leads to olfactory dysfunction causing anosmia.

18 Aug 2021

Specificity of serological assays against SARS-CoV-2 in patients with parasitic infections

A new study available on the pre-print server medRxiv* aims to assess the specificity of the serological assays of SARS-CoV-2 antibodies among patients known to have a tissue-borne parasitic infection or those who reside in areas where the virus is endemic.

18 Aug 2021